Skip to content

Clinical trials

Phase 3 Leukemia trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 3 Country / region: Poland Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20091
20101
20111
20123
20143
20161
20171
20191
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting3
Terminated2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Daiichi Sankyo3
Novartis Pharmaceuticals3
Acerta Pharma BV1
Amgen1
Antisoma Research1
Ariad Pharmaceuticals1
Gilead Sciences1
III. Medizinische Klinik Mannheim1
Institut de Recherches Internationales Servier1
Kura Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia18
Leukemia, Myeloid, Acute7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive5
Bronchiolitis Obliterans Syndrome4
Leukemia, Lymphocytic, Chronic, B-Cell4
Bone Marrow Diseases3
Hematologic Diseases3
Leukemia, Myeloid3
Neoplasms3
Hematologic Neoplasms2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.